Literature DB >> 2989295

Sequence rearrangements and genome instability. A possible step in carcinogenesis.

M Chorazy.   

Abstract

A substantial part of the mammalian genome is composed of sequences that do not contain structural genes. These sequences may constitute the major target for physical, chemical and biological DNA-damaging agents and can be involved in carcinogenesis. DNA-damaging agents contribute to the instability of the genome by introducing recombination-prone sites at DNA; these agents lead to extensive chromosomal lesions and rearrangements of genes and their regulatory sequences. Movable sequences that exist and operate in certain bacteria, yeast, and the fruit fly are responsible for sequence rearrangements and contribute to the majority of mutations. Their presence and role in higher animals is not well established. Extensive chromosomal rearrangements were identified in numerous malignancies in man and animals and definitely seem to represent a characteristic of malignancy. Vast chromosomal damage and sequence reshuffling may be of no less importance in the malignant transformation than the point mutation of a particular gene.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989295     DOI: 10.1007/bf00390351

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  63 in total

Review 1.  Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

Authors:  G Klein
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

2.  Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element.

Authors:  G Rechavi; D Givol; E Canaani
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

3.  Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.

Authors:  T H Rabbitts; P H Hamlyn; R Baer
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

4.  Translocation of immunoglobulin VH genes in Burkitt lymphoma.

Authors:  J Erikson; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

5.  Generalized recombination: nucleotide sequence homology between Chi recombinational hotspots.

Authors:  G R Smith; D W Schultz; J M Crasemann
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

6.  The role of gene dosage and genetic transpositions in carcinogenesis.

Authors:  G Klein
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

7.  Tumour promoter phorbol-12-myristate-13-acetate induces chromosomal damage via indirect action.

Authors:  I Emerit; P A Cerutti
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

8.  High mutation frequency in DNA transfected into mammalian cells.

Authors:  M P Calos; J S Lebkowski; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.

Authors:  K B Marcu; L J Harris; L W Stanton; J Erikson; R Watt; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange.

Authors:  S Cory; S Gerondakis; J M Adams
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  2 in total

Review 1.  Hormonal steroids act as tumour promoters by modulating oncogene expression.

Authors:  C E Sekeris
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 2.  Progression: the terminal stage in carcinogenesis.

Authors:  H C Pitot
Journal:  Jpn J Cancer Res       Date:  1989-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.